Pharmaceutical composition for treating post-traumatic brain syndrome

Abstract

The invention discloses a pharmaceutical composition for treating post-traumatic brain syndrome. The pharmaceutical composition is characterized by being prepared from the following materials: szechuan lovage rhizome, bark of oriental variegated coralbean, rhizome of Japanese galangal, radix achyranthis bidentatae, cowherb seed, thickleaf croton root, flos rosae rugosae, root of lemonfragrant ostericum, rhizome et radix notopterygii, radix angelicae pubescentis, photinia serrulata, seed of calyx-shaped carrierea, grassleaf sweelflag rhizome, flos chrysanthemi, uncariae ramulus cum uncis, radix bupleuri, succvinum amber, sargentgloryvine stem, dahurian patrinia herb, plantain seed, sweet wormwood herb, root of straight ladybel, cortex lycii, fructus lycii, semen cuscutae, radix astragali, radix ginseng rubra, radix angelicae sinensis and radix notoginseng. Brain collateral injure, a post-traumatic brain syndrome, causes blood stasis and weakness, and thus endogenous wind and exogenous wind seize the opportunity to get in; pathogenic wind blocks collaterals to cause pathogenic factors to block meridians, and thus causes exuberance of deficiency-heat; qi and blood are unsmooth to cause blood stasis, depression causes heat, and the pathogenesis is blood stasis, qi stagnation, blood stasis on head, qi-blood deficiency, and deficiency of liver and kidney. According to the invention, removing blood stasis and wind, promoting qi circulation, removing obstruction in collaterals, inducing resuscitation, promoting blood circulation, enriching blood and qi, soothing nerves, tonifying deficiency, nourishing liver and kidney, and tonifying brains are taken as rules of treatment so as to achieve the purpose of treating post-traumatic brain syndrome.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating sequelae of traumatic brain injury. Background technique [0002] Sequelae of traumatic brain injury refers to a group of autonomic nervous dysfunction or psychiatric symptoms that persist for more than three months after the recovery period of traumatic brain injury patients. Disorders, etc., clinical symptoms include varying degrees of loss of consciousness, headache, nervousness, irritability, attention disturbance, memory disturbance, nausea, dizziness, insomnia, fatigue, etc. , and memory loss are the most common. The sequelae of traumatic brain injury are more common in patients with mild or moderate closed craniocerebral trauma, and the incidence rate accounts for about 20% of patients with craniocerebral injury. It brings great pain and mental pressure to patients, and affects their work and life. More patients with post-traumatic brain injury are accompanied by symptoms of an...

AI Technical Summary

Problems solved by technology

For the treatment of sequelae of traumatic brain injury, there is currently a lack of drugs with definite curative effects, and there is also a lack of specific treatment methods in Western medicine.